Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05593211
Other study ID # SP-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 17, 2022
Est. completion date February 9, 2023

Study information

Verified date June 2023
Source Single Pass Inc
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective for this study is to assess safety and performance of the Kronos Electrocautery Device for electrocautery procedures following coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc.


Description:

The Kronos Electrocautery Device is intended to be used in electrocautery procedures to control bleeding by use of electrical current to heat the device probe tip that is applied directly to the target tissue area of treatment. Prospective, multi-center, single-arm study with consecutive, eligible subject enrollment at each site. Patients who require a coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc., will be eligible to participate in this study.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date February 9, 2023
Est. primary completion date February 9, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: 1. Patients undergoing a scheduled, elective, coaxial biopsy procedures on areas that include, but are not limited to, liver, kidney, lungs, breasts, soft tissue, etc., 2. Patients have signed an informed consent 3. Patients who are = 18 years of age Exclusion Criteria: 1. Patients with known bleeding disorder 2. Significant congenital anomaly or medical problem that in the opinion of the investigator would preclude enrollment in this study. 3. Women of childbearing potential who are pregnant, lactating, or planning to become pregnant during the course of the clinical investigation. 4. Active illness or active systemic infection or sepsis.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Kronos Electrocautery Device
The Kronos Electrocautery Device is a disposable electrocautery device that can cauterize deep tissue through a standard biopsy procedure guide needle. This device is intended to coagulate the tissue surrounding the core biopsy channel during withdrawal to reduce or eliminate significant post-procedural bleeding. Currently, the Kronos Electrocautery Device consists of one (1) size. As such, the existing Kronos Electrocautery Device is chosen as the worst-case condition

Locations

Country Name City State
United States Long Beach Memorial Medical Center Long Beach California

Sponsors (1)

Lead Sponsor Collaborator
Single Pass Inc

Country where clinical trial is conducted

United States, 

References & Publications (4)

Lim S, Rhim H, Lee MW, Song KD, Kang TW, Kim YS, Lim HK. New Radiofrequency Device to Reduce Bleeding after Core Needle Biopsy: Experimental Study in a Porcine Liver Model. Korean J Radiol. 2017 Jan-Feb;18(1):173-179. doi: 10.3348/kjr.2017.18.1.173. Epub 2017 Jan 5. — View Citation

Mahal AS, Knauer CM, Gregory PB. Bleeding after liver biopsy. West J Med. 1981 Jan;134(1):11-4. — View Citation

Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004 Oct;66(4):1570-7. doi: 10.1111/j.1523-1755.2004.00922.x. — View Citation

Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004 Jan;15(1):142-7. doi: 10.1097/01.asn.0000102472.37947.14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Absence of Hematoma Formation Patients will be contacted on day 14 post-procedure and asked a series of questions regarding Adverse Events related to the procedure. 14 days
Primary Measure and Categorize Amount of Blood Loss From Biopsy Access Site The weight of 10 gauze pads is taken prior to the procedure. Post-procedure, those same 10 gauze pads used at biopsy access site are weighed again to measure in grams, the amount of blood loss. The scale ranges from 1 (unacceptable) to 5 (excellent). 1 hour post procedure
Primary Absence of the Need for Ultrasound Examination Due to Observation of Bleeding Measuring the amount of patient who did not need an ultrasound examination due to observation of bleeding 8 hours post procedure
Secondary Absence of Secondary Reintervention Patients will be contacted on day 14 post-procedure and asked a series of questions regarding Adverse Events related to the procedure. Measuing the amount of patients who did not require secondary reintervention. 14 days
Secondary Time to Hospital Discharge 8 hours post procedure
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03672110 - Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen Phase 3
Completed NCT01545531 - Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance N/A
Recruiting NCT05700903 - Contributions to Hypertension With Androgen Deprivation Therapy Phase 4
Completed NCT03717883 - ADPKD Alterations in Hepatic Transporter Function
Withdrawn NCT04556721 - A Pharmacokinetic Study of Sugammadex in Dialysis Patients Phase 1
Active, not recruiting NCT04078750 - PLATO - Medication Adherence in Transplant Recipients N/A
Not yet recruiting NCT04531124 - Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
Completed NCT03107195 - Biokinetics Study of Tc-99m DMSA in Pediatric Molecular Imaging
Completed NCT03463148 - Validation of a Sensor for Non-Invasive Measurements
Recruiting NCT03578523 - Renal MR Feasibility in Renal Disease
Withdrawn NCT01468259 - A Multi-Center, Open-Label Study Phase 1
Completed NCT01256983 - Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation Phase 0
Completed NCT06070337 - H-Guard Pilot Safety Evaluation in Haemodialysis Patients N/A
Completed NCT03242343 - VasQ External Support for Arteriovenous Fistula N/A
Completed NCT03438123 - Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera N/A
Completed NCT01334333 - Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients Phase 4
Recruiting NCT05443321 - Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes N/A
Completed NCT04407182 - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 Phase 2
Not yet recruiting NCT06419270 - Cardiovascular, Renal, and Skeletal Complications in Patients With Post-Surgical Hypoparathyroidism
Not yet recruiting NCT04834089 - Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases Phase 1/Phase 2